Using StatXact to calculate tolerance intervals in studies with Poisson outcomes

Model Assisted Statistics and Applications

Volumn 4, Issue 2, 2009, Pages 117-122

  Zaslavsky, Boris G ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Clinical trial; Confidence probability; Poisson distribution; StatXact; Tolerance limit

Indexed keywords

EID: 67650535972     PISSN: 15741699     EISSN: None     Source Type: Journal    
DOI: 10.3233/MAS-2009-0112     Document Type: Article

References (24)

1. P. Armitage and T. Colton, Encyclopedia of Biostatistics, John Wiley & Sons, New York, 1998.
2. W.H. Beyer, CRC Standard Probability and Statistics Tables and Formulae, CRC Press Inc., Boca Raton, Ann Arbor, Boston, 1991.
3. E.B. Brown and H.K. Iyer, Tolerance intervals for assessing individual bioequivalence, Statistics in Medicine 16 (1997), 803-820.
4. S.C. Chow and J. Shao, Bioequivalence Review for Drug Interchangeability, Journal of Biopharmaceutical Statistics 9 (1999), 485-497.
5. E.P. Cowan, Draft Guidance Document: Review Approval Process for Rapid HIV Tests at FDA (BPAC). Food and Drug Administration, Center for Biologics Evaluation and Research. http://www.cdc.gov/hiv/pubs/rt/ B-Cowan.pdf.
6. CYTEL Software Corporation. StatXact 5 for Windows User's Manual. Cambridge, MA., 2001.
7. L.J. Dumont, W.H. Dzik, P. Rebulla, H. Brandwein, and the members of the BEST Working Party of the ISBT, Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT), Transfusion 36 (1996), 11-20.
8. J.D. Esinhart and V.M. Chinchilli, Sample size considerations for assessing individual bioequivalence based on the method tolerance interval, International Journal of Clinical Pharmacology Therapeutics 32 (1994), 26-32.
9. J.D. Esinhart and V.M. Chinchilli, Extension to the use of tolerance intervals for the assessment of individual bioequivalence, Journal of Biopharmaceutical Statistics 4 (1994), 39-52.
10. Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for Industry: Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion: www.fda.gov/ cber/gdlns/preleuk.pdf.
11. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Statistical Approaches to Establishing Bioequivalence: http://www.fda.gov/cder/guidance/3616fnl.htm
12. F. Garwood, Fiducial limits for the Poisson distribution, Biometrika 28 (1936), 437-442.
13. G.J. Hahn and W.Q. Meeker, Statistical Intervals, A Guide for Practitioners, John Wiley & Sons, Ins., New York, Chichester, Brisbane, Toronto, Singapore, 1991.
14. D. Hoffman and R. Kringle, Two-sided tolerance intervals for balanced and unbalanced random effects models, Journal of Biopharmaceutical Statistics 15 (2005), 283-293.
15. C. Jennen-Steinmetz and S. Wellek, A new approach to sample size calculation for reference interval studies, Statistics in Medicine 20 (2005), 3199-3212.
16. H.A. Katki, E.A. Engels and P.S. Rosenberg, Assessing uncertainty in reference intervals via tolerance intervals: Application to mixed model describing HIV infection, Statistics in Medicine 24 (2005), 3185-3198.
17. L.M. Moore and R.J. Beckman, Approximate one-sided tolerance bounds on the number of failures using Poisson regression, Technometrics 30 (1988), 283-290.
18. K. Sazama, Reports of 355 transfusion-associated deaths: 1976 through 1985, Transfusion 30 (1990), 583-590.
19. D.T. Shirke, R.R. Kumbhar and D. Kundu, Tolerance intervals for exponentiated scale family of distributions, Journal of Applied Statistics 32 (2005), 1067-1074.
20. W. Walter and R.S. Hauck, Modified two-sided normal tolerance intervals for batch acceptance of dose uniformity, Pharmaceutical Statistics 3 (2004), 89-97.
21. W.J. Westlake, Statistical aspects of comparative bioavailability Trials, Biometrics 35 (1979), 273-280.
22. S. Zacks, Uniformly most accurate upper tolerance limits for monotone likelihood ratio families of discrete distributions, JASA 65 (1970), 307-316.
23. S. Zacks, The theory of Statistical Inference, John Wiley & Sons, Inc., NY, London, Sydney, Toronto, 1971.
24. B.G. Zaslavsky, Calculation of tolerance limits and sample size determination for clinical trials with dichotomous outcomes, Journal of Biopharmaceutical Statistics 17 (2007), 1-11.